[PTX] YoY Quarter Result on 31-Dec-2016 [#Q2]

Stock
[PTX] Prescient Therapeutics Limited
Announcement Date
30-Dec-2016
Financial Year
2017
Quarter
31-Dec-2016 [#Q2]
Profit Trend
QoQ- 9.46%
YoY- -64.37%
Quarter Report
PTX's Result
PTX's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 599 711 457 563 712 31 0 -
PBT -2,296 -1,594 -1,180 -1,024 -623 -1,063 -1,186 11.63%
Tax -599 0 0 0 47 -12 -427 5.80%
NP -1,697 -1,594 -1,180 -1,024 -623 -1,063 -1,186 6.15%
Tax Rate - - - - - - - -
Total Cost 2,296 2,305 1,637 1,588 1,335 1,094 1,186 11.63%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -283.28 -224.38 -258.42 -181.76 -87.46 -3,413.87 -801,354.05 -73.39%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -0.00 -0.01 -0.01 -0.00 -0.01 -0.02 -0.06 -
EPS Diluted -0.00 -0.01 -0.01 -0.00 -0.01 -0.02 -0.06 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.